Home Atypical neurologic presentations of new onset type 1 diabetes mellitus in pediatric age group: a report of five unusual cases and review of the literature
Article
Licensed
Unlicensed Requires Authentication

Atypical neurologic presentations of new onset type 1 diabetes mellitus in pediatric age group: a report of five unusual cases and review of the literature

  • Laurel Mulder , Ozlem Onur , Lora Kleis , Heather Borders and Ayse P. Cemeroglu EMAIL logo
Published/Copyright: February 14, 2014
Journal of Pediatric Endocrinology and Metabolism
From the journal Journal of Pediatric Endocrinology and Metabolism Volume 27 Issue 7-8

Abstract

Type 1 diabetes mellitus (T1DM) is one of the most common chronic diseases in childhood and is caused by insulin deficiency resulting from the autoimmune destruction of insulin producing beta cells of the pancreas. Most children in the US with new onset T1DM present with the classic signs and symptoms of hyperglycemia and 30% with diabetic ketoacidosis (DKA). Neurologic manifestations are relatively rare and mostly include lethargy, decreased level of consciousness, and coma as a result of DKA. In this article, five cases of new onset T1DM with exceedingly rare or unreported neurologic manifestations in the pediatric age group are presented, along with a review of the literature.

Keywords: cerebellar ataxia; foot drop; hemiballismus-chorea; reversible peripheral neuropathy; stroke; type 1 diabetes mellitus
Corresponding author: Ayse P. Cemeroglu, MD, Associate Professor, Michigan State University, Spectrum Health Medical Group, Helen DeVos Children’s Hospital, Pediatric Endocrinology, 230 Michigan street, Suite 101, Grand Rapids, MI, USA, Phone: +616-391-3933, Fax: +616-391-6240, E-mail:

References

1. Haller MJ, Atkinson MA, Schatz D. Type 1 diabetes mellitus: etiology, presentation, and management. Pediatr Clin North Am 2005;52:1553.10.1016/j.pcl.2005.07.006Search in Google Scholar PubMed

2. Quinn M, Fleischman A, Rosner B, Nigrin DJ, Wolfsdorf JI. Characteristics at diagnosis of type 1 diabetes in children younger than 6 years. J Pediatr 2006;148:366.10.1016/j.jpeds.2005.10.029Search in Google Scholar PubMed

3. Galler A, Stange T, Müller G, Näke A, Vogel C, et al. Childhood Diabetes Registry in Saxony, Germany. Incidence of childhood diabetes in children aged less than 15 years and its clinical and metabolic characteristics at the time of diagnosis: data from the Childhood Diabetes Registry of Saxony, Germany. Horm Res Paediatr 2010;74:285–91.10.1159/000303141Search in Google Scholar PubMed

4. Gill P, Cemeroglu AP. Autoimmune cerebellar ataxia in a 14 year-old boy with type 1 diabetes mellitus. Case Rep Clin Pract Rev 2005;6:164–7.Search in Google Scholar

5. Roche EF, Menon A, Gill D, Hoey H. Clinical presentation of type 1 diabetes. Pediatr Diabetes 2005;6:75.10.1111/j.1399-543X.2005.00110.xSearch in Google Scholar PubMed

6. Petzold S, Kapellen T, Siekmeyer M, Hirsch W, Bartelt H, et al. Acute cerebral infarction and extra pontine myelinolysis in children with new onset type 1 diabetes mellitus. Pediatr Diabetes 2011;12:513–7.10.1111/j.1399-5448.2010.00732.xSearch in Google Scholar PubMed

7. Aye T, Reiss AL, Kesler S, Hoang S, Drobny J, et al. The feasibility of detecting neuropsychologic and neuroanatomic effects of type 1 diabetes in young children. Diabetes Care 2011;34: 1458–62.10.2337/dc10-2164Search in Google Scholar PubMed PubMed Central

8. Shoar Z, Dunne C, Yorns W, De Luca F, Rezvani G. Diabetic ketoacidosis with cerebral hemorrhage and alpha coma in an adolescent female. J Pediatr Endocrinol Metab 2013;26:561–4.10.1515/jpem-2012-0321Search in Google Scholar PubMed

9. Lee HS, Hwang JS. Cerebral infarction associated with transient visual loss in child with diabetic ketoacidosis. Diabeted Med 2011;28:516–8.10.1111/j.1464-5491.2011.03241.xSearch in Google Scholar PubMed

10. Northam EA, Rankins D, Lin A, Wellard RM, Pell GS, et al. Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 2009;32:445–50.10.2337/dc08-1657Search in Google Scholar PubMed PubMed Central

11. Hyllienmark L, Alstrand N, Jonsson B, Ludvigsson J, Cooray G, et al. Early electrophysiological abnormalities and clinical neuropathy: a prospective study in patients with type 1 diabetes. Diabetes Care 2013;36:3187–94.10.2337/dc12-2226Search in Google Scholar PubMed PubMed Central

12. Postuma RB, Lang AE. Hemiballism: revisiting a classic disorder. Lancet Neurol 2003;2:661–8.10.1016/S1474-4422(03)00554-4Search in Google Scholar

13. Burgunder JM. Recent advances in the management of choreas. Ther Adv Neurol Disord 2013;6:117–27.10.1177/1756285612471700Search in Google Scholar PubMed PubMed Central

14. Lin JJ, Lin GY, Shih C, Shen WC. Presentation of striatal hyperintensity on T1-weighted MRI in patients with hemiballism-hemichorea caused by non-ketotic hyperglycemia: report of seven new cases and a review of literature. J Neurol 2001;248:750–5.10.1007/s004150170089Search in Google Scholar PubMed

15. Hashimoto K, Ito Y, Tanahashi H, Hayashi M, Yamakita N, et al. Hyperglycemic chorea-ballism or acute exacerbation of Huntington’s chorea? Huntington’s disease unmasked by diabetic ketoacidosis in type 1 diabetes mellitus. J Clin Endocrinol Metab 2012;97:3016–20.10.1210/jc.2012-1190Search in Google Scholar PubMed

16. Awasthi D, Tiwari AK, Upadhyaya A, Singh B, Tomar GS. Ketotic hyperglycemia with movement disorder. J Emerg Trauma Shock 2012;5:90–1.10.4103/0974-2700.93095Search in Google Scholar PubMed PubMed Central

17. Alves C, Sampaio S, Barbosa V, Machado M. Acute chorea and type 1 diabetes mellitus: clinical and neuroimaging findings. Pediatr Diabetes 2012;13:e30–4.10.1111/j.1399-5448.2012.00856.xSearch in Google Scholar PubMed

18. Mihai CM, Catrinoiu D, Stoicescu RM. Atypical onset of diabetes in a teenage girl: a case report. Cases J 2008;1:425.10.1186/1757-1626-1-425Search in Google Scholar PubMed PubMed Central

19. Abe Y, Yamamoto T, Soeda T, Kumagai T, Tanno Y, et al. Diabetic striatal disease: clinical presentation, neuroimaging, and pathology. Intern Med 2009;48:1135–41.10.2169/internalmedicine.48.1996Search in Google Scholar PubMed

20. Cadario F, Moreno G, Esposito S, Peruzzi C, Bona G. Transient chorea in a patient with type 1 diabetes may induce a reduction in insulin demand through increased spontaneous movements. Minerva Pediatr 2007;59:49–52.Search in Google Scholar

21. Bandyopadhyay SK, Dutta A. Hemifacial spasm complicating diabetic ketoacidosis. J Assoc Phys India 2005;53:649–50.Search in Google Scholar

22. Lai PH, Chen PC, Chang MH, Pan HB, Yang CF, et al. In vivo proton MR spectroscopy of chorea-ballismus in diabetes mellitus. Neuroradiology 2001;43:525–31.10.1007/s002340100538Search in Google Scholar PubMed

23. Felicio AC, Chang CV, Godeiro-Junior C, Okoshi MP, Ferraz HB. Hemichorea-hemiballism as the first presentation of type 2 diabetes mellitus. Arq Neuropsiquiatr 2008;66:249–50.10.1590/S0004-282X2008000200022Search in Google Scholar PubMed

24. Kim HJ, Moon WJ, Oh J, Lee IK, Kim HY, et al. Subthalamic lesion on MR imaging in a patient with nonketotic hyperglycemia-induced hemiballism. Am J Neuroradiol 2008;29:526–7.10.3174/ajnr.A0927Search in Google Scholar

25. Kranick SM, Price RS, Prasad S, Hurtig HI. Clinical reasoning: a 52-year-old woman with subacute hemichorea. Neurology 2008;71:e59–62.10.1212/01.wnl.0000334759.72146.39Search in Google Scholar

26. Erlander MG, Tillakaratne NJ, Feldblum S, Patel N, Tobin AJ. Two genes encode distinct glutamate decarboxylases. Neuron 1991;7:91–100.10.1016/0896-6273(91)90077-DSearch in Google Scholar

27. Dalakas MC, Fujii M, Li M, McElroy B. The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 2000;55:1531–5.10.1212/WNL.55.10.1531Search in Google Scholar PubMed

28. Levy LM, Dalakas MC, Floeter MK. The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid. Ann Intern Med 1999;131:522–30.10.7326/0003-4819-131-7-199910050-00008Search in Google Scholar PubMed

29. Walikonis JE, Lennon VA. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. Mayo Clin Proc 1998;73:1161–6.10.4065/73.12.1161Search in Google Scholar PubMed

30. McKeon A, Robinson MT, McEvoy KM, Matsumoto JY, Lennon VA, et al. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol 2012;69:230–8.10.1001/archneurol.2011.991Search in Google Scholar PubMed

31. Saiz A, Blanco Y, Sabater L, Gonzalez F, Bataller L, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008;131:2553–63.10.1093/brain/awn183Search in Google Scholar PubMed

32. Iwasaki H, Sato R, Shichiri M, Hirata Y. A patient with type 1 diabetes mellitus and cerebellar ataxia associated with high titer of circulating anti-glutamic acid decarboxylase antibodies. Endocr J 2001;48:261–8.10.1507/endocrj.48.261Search in Google Scholar PubMed

33. Nanri K, Niwa H, Mitoma H, Takei A, Ikeda J, et al. Low-titer anti-GAD-antibody-positive cerebellar ataxia. Cerebellum 2013;12:171–5.10.1007/s12311-012-0411-5Search in Google Scholar PubMed

34. Takagi M, Ishigaki Y, Uno K, Sawada S, Imai J, et al. Cognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study. BMC Neurol 2013;13:76.10.1186/1471-2377-13-76Search in Google Scholar PubMed PubMed Central

35. Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010;67:470–8.10.1002/ana.21917Search in Google Scholar PubMed

36. Akman CI, Patterson MC, Rubinstein A, Herzog R. Limbic encephalitis associated with anti-GAD antibody and common variable immune deficiency. Dev Med Child Neurol 2009;51:563–7.10.1111/j.1469-8749.2008.03217.xSearch in Google Scholar PubMed

37. Ledet DS, Handgretinger R, Bertorini TE, Hale GA, Ribeiro RC, et al. Leucoencephalopathy, transverse myelopathy, and peripheral neuropathy in association with glutamic acid decarboxylase-65 (GAD) antibodies in children with cancer. J Child Neurol 2008;23:1357–62.10.1177/0883073808315617Search in Google Scholar PubMed

38. Korff CM, Parvex P, Cimasoni L, Wilhelm-Bals A, Hampe CS, et al. Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition? Arch Neurol 2011;68:1065–8.10.1001/archneurol.2011.177Search in Google Scholar PubMed

39. Lee SS, Han HS, Kim H. A 5-yr follow-up nerve conduction study for the detection of subclinical diabetic neuropathy in children with newly diagnosed insulin-dependent diabetes mellitus. Pediatr Diabetes 2010;11:521–8.10.1111/j.1399-5448.2009.00636.xSearch in Google Scholar PubMed

40. Wilson JL, Sokol DK, Smith LH, Snook RJ, Waguespack SG, et al. Acute painful neuropathy (insulin neuritis) in a boy following rapid glycemic control for type 1 diabetes mellitus. J Child Neurol 2003;18:365–7.10.1177/08830738030180051701Search in Google Scholar PubMed

41. Blankenburg M, Kraemer N, Hirschfeld G, Krumova EK, Maier C, et al. Childhood diabetic neuropathy: functional impairment and non-invasive screening assessment. Diabetes Med 2012;29:1425–32.10.1111/j.1464-5491.2012.03685.xSearch in Google Scholar PubMed

42. Riihimaa PH, Suominen K, Tolonen U, Jantii V, Knip M, et al. Peripheral nerve function is increasingly impaired during puberty in adolescents with type 1 diabetes. Diabetes Care 2001;24:1087–92.10.2337/diacare.24.6.1087Search in Google Scholar PubMed

43. Moore DJ, Gregory JM, Kumah-Crystal YA, Simmons JH. Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence. Vasc Health Risk Manag 2009;5:1015–31.Search in Google Scholar

44. Moser JT, Langdon DR, Finkel RS, Ratcliffe SJ, Foley LR, et al. The evaluation of peripheral neuropathy in youth with type 1 diabetes. Diabetes Res Clin Pract 2013;100:e3–6.10.1016/j.diabres.2013.01.015Search in Google Scholar PubMed

45. Louraki M, Karayianni C, Kanaka-Gantenbein C, Katsalouli M, Karavanaki K. Peripheral neuropathy in children with type 1 diabetes. Diabetes Metab 2012;38:281–9.10.1016/j.diabet.2012.02.006Search in Google Scholar

46. Meh D, Denislic M. Subclinical neuropathy in type I diabetic children. Electroencephalogr Clin Neurophysiol 1998;109: 274–80.10.1016/S0924-980X(98)00017-4Search in Google Scholar

47. van der Heyden J, van der Meer P, Birnie E, de Coo I, Castro Cabezas M, et al. Decreased excitability of the distal motor nerve of young patients with type 1 diabetes mellitus. Pediatr Diabetes 2013;14:519–25.10.1111/pedi.12048Search in Google Scholar

48. Zeitler P, Haqq A, Rosenbloom A, Glaser N; Drugs and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Hyperglycemic hyperosmolar syndrome in children: pathophysiological considerations and suggested guidelines for treatment. J Pediatr 2011;158:9–14.10.1016/j.jpeds.2010.09.048Search in Google Scholar

49. Canarie MF, Bogue CW, Banasiak KJ, Weinzimer SA, Tamborlane WV. Decompensated hyperglycemic hyperosmolarity without significant ketoacidosis in the adolescent and young adult population. J Pediatr Endocrinol Metab 2007;20:1115–24.10.1515/JPEM.2007.20.10.1115Search in Google Scholar

50. Rosenbloom AL. Hyperglycemic crises and their complications in children. J Pediatr Endocrinol Metab 2007;20:5–18.10.1515/JPEM.2007.20.1.5Search in Google Scholar

51. Rosenbloom AL. Hyperglycemic hyperosmolar state: an emerging pediatric problem. J Pediatr 2010;156:180–4.10.1016/j.jpeds.2009.11.057Search in Google Scholar

52. Bagdure D, Rewers A, Campagna E, Sills MR. Epidemiology of hyperglycemic hyperosmolar syndrome in children hospitalized in USA. Pediatr Diabetes 2013;14:18–24.10.1111/j.1399-5448.2012.00897.xSearch in Google Scholar

53. Belmonte MM, Colle E, Murphy DA, Wiglesworth FW. Nonketotic hyperosmolar diabetic coma in Down’s syndrome. J Pediatr 1970;77:879–81.10.1016/S0022-3476(70)80254-2Search in Google Scholar

54. Green DA. Nonketotic hyperosmolar diabetic coma in an infant with Down syndrome. Clin Pediatr (Phila) 1999;38:317–18.10.1177/000992289903800517Search in Google Scholar PubMed

55. Multari G, Werner B, Cervoni M, Lubrano R, Costantino F, et al. Peritoneal dialysis in an infant with type 1 diabetes and hyperosmolar coma. J Endocrinol Invest 2001;24:104–6.10.1007/BF03343822Search in Google Scholar PubMed

56. Kapellen T, Vogel C, Telleis D, Siekmeyer M, Kiess W. Treatment of diabetic ketoacidosis (DKA) with 2 different regimens regarding fluid substitution and insulin dosage (0.025 vs. 0.1 units/kg/h). Exp Clin Endocrinol Diabetes 2012;120:273–6.Search in Google Scholar

57. Vernon DD, Postellon DC. Nonketotic hyperosmolal diabetic coma in a child: management with low-dose insulin infusion and intracranial pressure monitoring. Pediatrics 1986;77:770–2.10.1542/peds.77.5.770Search in Google Scholar

58. Ahlsson F, Gedeborg R, Hesselager G, Tuvemo T, Enblad P. Treatment of extreme hyperglycemia monitored with intracerebral microdialysis. Pediatr Crit Care Med 2004;5:89–92.10.1097/01.PCC.0000102396.02043.22Search in Google Scholar PubMed

59. Arieff AI. Cerebral edema complicating nonketotic hyperosmolar coma. Miner Electrolyte Metab 1986;12:383–9.Search in Google Scholar

60. Carchman RM, Dechert-Zeger M, Calikoglu AS, Harris BD. A new challenge in pediatric obesity: pediatric hyperglycemic hyperosmolar syndrome. Pediatr CritCare Med 2005;6:20–4.10.1097/01.PCC.0000149134.61673.77Search in Google Scholar PubMed

61. Katirji MB, Wilbourn AJ. Common peroneal mononeuropathy: a clinical and electrophysiologic study of 116 lesions. Neurology 1988;38:1723–8.10.1212/WNL.38.11.1723Search in Google Scholar

62. Aprile I, Padua L, Padua R, D’Amico P, Meloni A, et al. Peroneal mononeuropathy: predisposing factors, and clinical and neurophysiological relationships. Neurol Sci 2000;21:367–71.10.1007/s100720070052Search in Google Scholar PubMed

63. Bendszus M, Reiners K, Perez J, Solymosi L, Koltzenburg M. Peroneal nerve palsy caused by thrombosis of crural veins. Neurology 2002;58:1675–7.10.1212/WNL.58.11.1675Search in Google Scholar PubMed

64. Sherman DG, Easton JD. Dieting and peroneal nerve palsy. J Am Med Assoc 1977;238:230–1.10.1001/jama.1977.03280030038018Search in Google Scholar

65. Shahar E, Landau E, Genizi J. Adolescence peroneal neuropathy associated with rapid marked weight reduction: case report and literature review. Eur J Paediatr Neurol 2007;11:50–4.10.1016/j.ejpn.2006.10.008Search in Google Scholar PubMed

66. Weyns FJ, Beckers F, Vanormelingen L, Vandersteen M, Niville E. Foot drop as a complication of weight loss after bariatric surgery: is it preventable? Obes Surg 2007;17:1209–12.10.1007/s11695-007-9203-2Search in Google Scholar PubMed

67. Elias WJ, Pouratian N, Oskouian RJ, Schirmer B, Burns T. Peroneal neuropathy following successful bariatric surgery. Case report and review of the literature. J Neurosurg 2006;105:631–5.10.3171/jns.2006.105.4.631Search in Google Scholar PubMed

68. Cruz-Martinez A, Arpa J, Palau F. Peroneal neuropathy after weight loss. J Peripher Nerv Syst 2000;5:101–5.10.1046/j.1529-8027.2000.00007.xSearch in Google Scholar PubMed

Received: 2013-7-29
Accepted: 2013-12-27
Published Online: 2014-2-14
Published in Print: 2014-7-1

©2014 by Walter de Gruyter Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Welcome to Assistant Editors at JPEM
  4. Review article
  5. Common approach to childhood obesity in Japan
  6. Images in pediatric endocrinology
  7. Aromatase deficiency in an adolescent girl misdiagnosed as congenital adrenal hyperplasia in infancy and childhood
  8. Original articles
  9. Prevalence of vitamin D deficiency among Iranian adolescents
  10. Analysis of body composition among children and adolescents – a cross-sectional study of the Polish population and comparison of body fat measurement methods
  11. Association of rs8066560 variant in the sterol regulatory element-binding protein 1 (SREBP-1) and miR-33b genes with hyperglycemia and insulin resistance
  12. Differences in anxiety and depression between male and female caregivers of children with a disorder of sex development
  13. Fasting and postprandial levels of a novel anorexigenic peptide nesfatin in childhood obesity
  14. The effect of growth hormone treatment on height in children with idiopathic short stature
  15. Clinical characteristics of type 1 diabetes over a 40 year period in Turkey: secular trend towards earlier age of onset
  16. Relationships of gamma-glutamyltransferase and beta 2-microglobulin on high sensitivity C-reactive protein among Japanese elementary school children
  17. Evaluation of insulin resistance and metabolic syndrome in a group of obese Czech children
  18. Circulating intact parathyroid hormone is suppressed at 25-hydroxyvitamin D concentrations >25 nmol/L in children
  19. Association between vitamin D level and cardiovascular risk in obese children and adolescents
  20. Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents
  21. Clinical features at diagnosis and responses to antithyroid drugs in younger children with Graves’ disease compared with adolescent patients
  22. Influence of hormonal parameters, bone mineral density and bone turnover on fracture risk in healthy male adolescents: a case control study
  23. Evaluation of lipid and glucose metabolism and cortisol and thyroid hormone levels in obese appropriate for gestational age (AGA) born and non-obese small for gestational age (SGA) born prepubertal Slovak children
  24. Chitotriosidase as a possible marker of clinically evidenced atherosclerosis in dyslipidemic children
  25. Exhaled carbon monoxide in adolescents with diabetic cardiovascular autonomic neuropathy
  26. Gut hormone profiles in preterm and term infants during the first 2 months of life
  27. Outcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and/or rapid pubertal progress: a retrospective chart review
  28. A deletion including exon 2 of the TSHR gene is associated with thyroid dysgenesis and severe congenital hypothyroidism
  29. Steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT) in childhood
  30. Patient Reports
  31. Neonatal diabetes in an infant of diabetic mother: same novel INS missense mutation in the mother and her offspring
  32. Atypical neurologic presentations of new onset type 1 diabetes mellitus in pediatric age group: a report of five unusual cases and review of the literature
  33. Importance of dietary calcium and vitamin D in the treatment of hypercalcaemia in Williams-Beuren syndrome
  34. Vitamin D intoxication in two brothers: be careful with dietary supplements
  35. Transient diabetes insipidus in a preterm neonate and the challenge of desmopressin dosing
  36. A rare case of hypoglycaemia due to insulinoma in an adolescent with acutely altered mental status
  37. Holoprosencephaly: ZIC2 mutation in a case with panhypopituitarism
  38. An association of hypochondroplasia and immune deficiency
  39. Hypophosphatemic rickets caused by a novel PHEX gene mutation in an Indian girl
  40. Psoriasis vulgaris and autoimmune polyendocrine syndrome type I: a case report
  41. Identification of a combined missense/splice-site mutation in FAH causing tyrosinemia type 1
  42. Letter to the Editor
  43. Vitamin D intake and premature infants with intraventricular hemorrhage: how advisable is it?
https://doi.org/10.1515/jpem-2013-0312
Keywords for this article
cerebellar ataxia; foot drop; hemiballismus-chorea; reversible peripheral neuropathy; stroke; type 1 diabetes mellitus

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Welcome to Assistant Editors at JPEM
  4. Review article
  5. Common approach to childhood obesity in Japan
  6. Images in pediatric endocrinology
  7. Aromatase deficiency in an adolescent girl misdiagnosed as congenital adrenal hyperplasia in infancy and childhood
  8. Original articles
  9. Prevalence of vitamin D deficiency among Iranian adolescents
  10. Analysis of body composition among children and adolescents – a cross-sectional study of the Polish population and comparison of body fat measurement methods
  11. Association of rs8066560 variant in the sterol regulatory element-binding protein 1 (SREBP-1) and miR-33b genes with hyperglycemia and insulin resistance
  12. Differences in anxiety and depression between male and female caregivers of children with a disorder of sex development
  13. Fasting and postprandial levels of a novel anorexigenic peptide nesfatin in childhood obesity
  14. The effect of growth hormone treatment on height in children with idiopathic short stature
  15. Clinical characteristics of type 1 diabetes over a 40 year period in Turkey: secular trend towards earlier age of onset
  16. Relationships of gamma-glutamyltransferase and beta 2-microglobulin on high sensitivity C-reactive protein among Japanese elementary school children
  17. Evaluation of insulin resistance and metabolic syndrome in a group of obese Czech children
  18. Circulating intact parathyroid hormone is suppressed at 25-hydroxyvitamin D concentrations >25 nmol/L in children
  19. Association between vitamin D level and cardiovascular risk in obese children and adolescents
  20. Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents
  21. Clinical features at diagnosis and responses to antithyroid drugs in younger children with Graves’ disease compared with adolescent patients
  22. Influence of hormonal parameters, bone mineral density and bone turnover on fracture risk in healthy male adolescents: a case control study
  23. Evaluation of lipid and glucose metabolism and cortisol and thyroid hormone levels in obese appropriate for gestational age (AGA) born and non-obese small for gestational age (SGA) born prepubertal Slovak children
  24. Chitotriosidase as a possible marker of clinically evidenced atherosclerosis in dyslipidemic children
  25. Exhaled carbon monoxide in adolescents with diabetic cardiovascular autonomic neuropathy
  26. Gut hormone profiles in preterm and term infants during the first 2 months of life
  27. Outcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and/or rapid pubertal progress: a retrospective chart review
  28. A deletion including exon 2 of the TSHR gene is associated with thyroid dysgenesis and severe congenital hypothyroidism
  29. Steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT) in childhood
  30. Patient Reports
  31. Neonatal diabetes in an infant of diabetic mother: same novel INS missense mutation in the mother and her offspring
  32. Atypical neurologic presentations of new onset type 1 diabetes mellitus in pediatric age group: a report of five unusual cases and review of the literature
  33. Importance of dietary calcium and vitamin D in the treatment of hypercalcaemia in Williams-Beuren syndrome
  34. Vitamin D intoxication in two brothers: be careful with dietary supplements
  35. Transient diabetes insipidus in a preterm neonate and the challenge of desmopressin dosing
  36. A rare case of hypoglycaemia due to insulinoma in an adolescent with acutely altered mental status
  37. Holoprosencephaly: ZIC2 mutation in a case with panhypopituitarism
  38. An association of hypochondroplasia and immune deficiency
  39. Hypophosphatemic rickets caused by a novel PHEX gene mutation in an Indian girl
  40. Psoriasis vulgaris and autoimmune polyendocrine syndrome type I: a case report
  41. Identification of a combined missense/splice-site mutation in FAH causing tyrosinemia type 1
  42. Letter to the Editor
  43. Vitamin D intake and premature infants with intraventricular hemorrhage: how advisable is it?
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 20.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0312/html
Scroll to top button